Alabama Administrative Code › Title 580 - ALABAMA DEPARTMENT OF MENTAL HEALTH › Chapter 580-9-44 - PROGRAM OPERATIONS › Section 580-9-44-.28 - Level 3.7-D: Medically Monitored Residential Detoxification Program And Level 3.7-D NTP: Medically Monitored Residential Detoxification Narcotic Treatment Program

Current through Register Vol. 42, No. 9, June 28, 2024
(1)
			 Scope. This Chapter establishes rules for the operation of Medically Monitored
			 Residential Detoxification Programs (Level 3.7-D) and Medically Monitored
			 Residential Detoxification Programs designated as Narcotic Treatment Programs
			 (Level 3.7-D NTP).
(2) Definitions.
			 The following definitions apply to this Chapter:
(a) Accreditation elements: The standards
			 that are developed and adopted by an accreditation body and approved by the
			 Substance Abuse and Mental Health Services Administration (SAMHSA).
(b) Detoxification: The dispensing of
			 medication, approved for such purposes, in decreasing doses to an individual to
			 alleviate adverse physical or psychological effects incident to withdrawal from
			 the continuous or sustained use of alcohol and/or other relevant addictive
			 drugs. Detoxification functions, also, as a method of bringing the individual
			 to a drug-free state within such period.
(c) Federal opioid treatment standards:
			 42 CFR
			 8.12.
(d) Level 3.7-D Medically Monitored
			 Residential Detoxification Program: An organized regimen of services provided
			 by nursing and medical professionals, which provides for 24-hour medically
			 supervised alcohol or other drug withdrawal management with medication approved
			 for such use.
(e) Level 3.7-D NTP
			 Medically Monitored Residential Detoxification Program: An organized regimen of
			 services provided by nursing and medical professionals, which provides for
			 24-hour medically supervised opioid withdrawal management utilizing
			 buprenorphine or a buprenorphine combination product approved for treatment of
			 opioid use disorders by the Food and Drug Administration (FDA). A Level 3.7-D
			 NTP may not dispense Methadone unless the entity is certified by the Alabama
			 Department of Mental Health to operate an Opioid Treatment Program in
			 compliance with Chapter
			 580-9-44-.29 of these rules and holds a valid Certificate of Need for the operation of a
			 Methadone Treatment Program issued by the Alabama State Health Planning and
			 Development Agency.
(f) Long-term
			 detoxification: Detoxification treatment services provided for a period more
			 than 30 days, but not in excess of 180 days.
(g) Medical director: A physician, licensed
			 to practice medicine in Alabama, who assumes responsibility for administering
			 all medical services performed by the program, either by performing them
			 directly or by delegating specific responsibility to authorized program
			 physicians and healthcare professionals functioning under the medical
			 director's direct supervision.
(h)
			 Program sponsor: The individual, named in the entity's application for
			 certification by SAMHSA as according to
			 42 CFR
			 8.11, who is responsible for the operation of
			 the Level 3.7-D NTP. The sponsor assumes responsibility for all of the entity's
			 employees, including any practitioners, agents, or other persons providing
			 medical, rehabilitative, or counseling services.
(i) Short-term detoxification: Detoxification
			 treatment for a period not in excess of 30 days.